Bacillus Anthracis Edema Toxin Acts As an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens.
From: Department of Microbiology, University of Alabama at Birmingham, AL 35294, USA.
Journal of immunology (Baltimore, Md. : 1950)
- Publish Date: Feb 2006
- ISSN: 0022-1767
- Volume: 176
- Issue: 3
- Pages: 1776-83
- Medium: Print
- Language: English
- Citation (JAMA): Duverger Alexandra, Jackson Raymond J, van Ginkel Frederick W, et al. Bacillus Anthracis Edema Toxin Acts As an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens.. J. Immunol. Feb 2006;176:1776-83
Abstract
Anthrax edema toxin (EdTx) is an AB-type toxin that binds to anthrax toxin receptors on target cells via the binding subunit, protective Ag (PA). Edema factor, the enzymatic A subunit of EdTx, is an adenylate cyclase. We found that nasal delivery of EdTx enhanced systemic immunity to nasally coadministered OVA and resulted in high OVA-specific plasma IgA and IgG (mainly IgG1 and IgG2b). The edema factor also enhanced immunity to the binding PA subunit itself and promoted high levels of plasma IgG and IgA responses as well as neutralizing PA Abs. Mice given OVA and EdTx also exhibited both PA- and OVA-specific IgA and IgG Ab responses in saliva as well as IgA Ab responses in vaginal washes. EdTx as adjuvant triggered OVA- and PA-specific + T cells which secreted IFN-gamma and selected Th2-type cytokines. The EdTx up-regulated costimulatory molecule expression by APCs but was less effective than cholera toxin for inducing IL-6 responses either by APCs in vitro or in nasal washes in vivo. Finally, nasally administered EdTx did not target CNS tissues and did not induce IL-1 mRNA responses in the nasopharyngeal-associated lymphoepithelial tissue or in the olfactory bulb epithelium. Thus, EdTx derivatives could represent an alternative to the ganglioside-binding enterotoxin adjuvants and provide new tools for inducing protective immunity to PA-based anthrax vaccines.
Mesh Headings (Keywords): Adenylate Cyclase, Adjuvants, Immunologic, Administration, Inhalation, Animals, Antibodies, Antigens, Bacterial, Bacillus anthracis, Cells, Cultured, Cytokines, Exotoxins, Female, Immunity, Mucosal, Macrophages, Mice, Mice, Inbred C57BL, Ovalbumin, Saliva, T-Lymphocytes, Vaccines, Vagina
Check for Full Text / PubMed Unique Identifier (PMID): 16424208
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.